Still missing the talk that went with the slides! But, basically...is it a different kind of melanoma in that subset of patients around the facillity....or do we all just need to make a run for M D Anderson?????
www.oncologycongress.com/rna/rna_OncologyCongress_v2/documents/2011/session_presentations/Prognostic_Heterogeneity_in_Patients_with_Stage_IV_Disease-Atkins.pdf
odd... but I kind of chalk it up to a difference in record keeping and such. Of course, a run for M D Anderson couldn't hurt!
ReplyDelete